Affiliation:
1. Department of Health, Physical Education and Recreation, University of Cape Coast, Cape Coast CC 3321, Ghana
2. Neurocognition and Action-Biomechanics-Research Group, Faculty of Psychology and Sports Science, Bielefeld University, Postfach 10 01 31, 33501 Bielefeld, Germany
Abstract
Students’ and teachers’ acceptance of the COVID-19 vaccination may help boost the uptake of the vaccines in the general population because teachers and students serve as a source of information and campaign mechanisation for vaccination. This review aimed to map evidence on the prevalence and predictors of COVID-19 vaccine acceptance and hesitancy among teachers and students. After removing duplicates, a search in several databases (Dimensions, PubMed Central, JSTOR, Google Scholar, Google, the WHO Library, and HINARI) produced 2060 records. Through screening based on the inclusion criteria, 27 records were used for this review. A relatively high prevalence of vaccine hesitancy was found among teachers and students. Teachers and students in countries such as China, Egypt, the USA, and India however, reported relatively low levels of COVID-19 vaccine acceptance. Vaccine hesitancy depends on perceived adverse effects, safety, efficacy, and benefits among teachers and students, with male teachers and male students being more likely to accept the COVID-19 vaccine than their female counterparts. Moreover, we found that vaccine acceptance could result from trust in the healthcare system and pharmaceutical companies, sources of COVID-19 information, and trust in healthcare providers. Public health experts, academics, other scientists, and health practitioners are required to take a more distinctive, multidisciplinary, and structured approach that focused on communicating effective evidence-based information to combat misinformation concerning COVID-19 vaccines.
Funder
Institutional Open Access Publication Fund
Reference56 articles.
1. WHO (2024, April 11). WHO Coronavirus (COVID-19) Dashboard 2024. Available online: https://data.who.int/dashboards/covid19/cases?n=c.
2. The Concept of Classical Herd Immunity May Not Apply to COVID-19;Morens;J. Infect. Dis.,2022
3. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar;Tang;Nat. Med.,2021
4. COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA;Vilches;Lancet Reg. Health Am.,2022
5. Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: A modeling study;Shoukat;Lancet Reg. Health Am.,2022